News

Warning: The Illinois government’s plan to export medical tyranny nationwide and how to stop it

(by Stand for Health Freedom.com) – The Illinois government, long known for systemic corruption, has more recently become known for imposing on its residents and visitors some of the most draconian COVID-19 restrictions in the country. Even though most Americans think the COVID-19 pandemic is in the rearview mirror, Illinois’ corrupt government continues to advance a plan to dominate public health nationwide through an infectious disease testing and treatment surveillance regime. The plan involves taking control of your life and your children’s lives by coercing unwanted medical procedures and restricting activities using a compliance scheme called the “Do to Do” model.

Picture1

Pg. 14 of Power Point Presentation: SHIELD U.S. A COVID-19 testing system to get the U.S. back up and running more safely as we bridge to widespread vaccination. University of Illinois System (Dec. 14, 2020)

According to the plan uncovered as part of a Freedom of Information Act (FOIA) request, citizens are expected to “do” what is required, such as accept vaccination, to be able to “do” what they intend, such as go to a restaurant. The infrastructure necessary to support such a system for COVID and a whole host of diseases, is currently quietly being built out, with all expenses paid by taxpayers. In fact, during January and February of 2022, the City of Chicago implemented a “Do to Do” requirement. Citizens were required to show proof of vaccination or a negative COVID test to participate in a variety of indoor activities including going to the gym, attending a movie or show, or visiting a museum.

The plan coming out of Illinois is being deployed by a for-profit, university-related company called Shield T3, which is owned by the University of Illinois. And as of April 2022, Shield T3 had already incorporated in 20 states. So, if you haven’t heard of Shield T3 and you care about freedom and liberty, this is truly a must-read article.

Shield T3 – T3 standing for Target, Test, and Tell – has a suite of products including: a saliva-based test for COVID-19 called covidSHIELD, a proximity tracing app, a vaccine/health passport app, an agent-based modelling project, and a school-based program called Test to Stay. The SHIELD plan was first implemented at the University of Illinois, which for students felt much more like a prison than a university.

SHIELD’s initial plan is to build testing hubs with a capacity of 100,000 tests per day in the 25 largest U.S. cities and then build mobile labs with a capacity of 10,000 tests per day in the 50 next-largest U.S. cities and at all major universities.

Picture2

Pg. 20 of Power Point Presentation: SHIELD U.S. A COVID-19 testing system to get the U.S. back up and running more safely as we bridge to widespread vaccination. University of Illinois System (Dec. 14, 2020)

The SHIELD plan, originally code named “the Manhattan Project” by scientists at the university who were developing it, was presented to then-President-elect Joe Biden’s team in December 2020.  Invoking the World War II era code name for the project that led to the creation of the first atomic bombs is likely no accident. There’s a world war raging for control of human health, human freedom, and, likely, even humanity itself under the guise of protecting public health. The so-called “pandemic” caused by COVID-19 is clearly but the first battle. What’s happening right now is a deployment of the necessary infrastructure to support a private-public partnership for medical tyranny all across this country.

Premised on the notion of pandemic risk, since 2020, SHIELD has built out a massive COVID testing and surveillance infrastructure in Illinois funded almost entirely by federal pandemic relief dollars, which were earmarked for SHIELD’s exclusive use by Illinois’ billionaire democrat governor JB Pritzker, and taxpayer funds held by the University of Illinois. And while the perception of pandemic risk is now greatly diminished, a recent Shield T3 slide presentation stated that “Shield T3 is continuing to pursue opportunities to build a business for the long-term.” Shield T3’s plan is to increase its disease surveillance in at least three ways: (1) broadening its network of testing facilities; (2) increasing the number of diseases tested for by SHIELD tests; and, (3) performing more in-depth and detailed tests on people.

Picture3

Pg. 4 of Power Point Presentation: SHIELD T3 Executive Committee Meeting Public Session. University of Illinois System (Feb. 11, 2022).

The SHIELD testing program currently centers around a saliva-based Polymerase Chain Reaction (PCR) test for COVID-19. As fear of COVID fades and vaccine failure becomes very widely recognized, however, COVID-19 is being seen as an endemic disease, and therefore, one of many background infectious diseases. So, Shield T3’s plan is to rapidly repurpose existing PCR equipment and infrastructure to test not only for COVID-19 but also for any number of other diseases including, most notably, influenza and RSV.

A recent job posting on LinkedIn gave a clear indication of where the company is headed: “Shield T3 Health is a mission-based molecular diagnostics company that provides high-quality, low-cost COVID19 diagnostics and molecular microbiology testing. We provide our clinical testing services through our CLIA-accredited laboratories that are currently located in Sunnyvale and Claremont in CA; Washington, DC; Georgetown, KY; Orono, ME; Chicago, IL; Dallas, TX; and Madison, WI.”

The Shield T3 job posting went on: “We are rapidly expanding into other areas of health care and clinical diagnostics testing. We are looking for a versatile molecular biology technologist to develop the technology necessary to develop state-of-the-art assays for microbiology, infectious diseases, genetics, genomics, and oncology with a special focus on PCR-based genotyping and next-generation sequencing-based laboratory-developed assays or IVD products.”

Shield T3’s expansion in terms of both geography and diversity of test offerings has followed the objectives outlined in several Rockefeller Foundation documents. And it should be noted that the Rockefeller Foundation provided grants and a strategic partnership to the University of Illinois to help SHIELD become established and expand. Of note is a March 2022 Rockefeller Foundation paper titled “Getting to and Sustaining the Next Normal — A Roadmap for Living with COVID” wherein a roadmap to the “next normal” is outlined. One of the most notable suggestions that “[t]he Administration should develop a national program for serological and, if possible, cellular immunology surveillance to complement viral surveillance programs… To enable this work, the federal government should establish an interoperable, electronic, national verification system to capture vaccination data, positive SARS-CoV-2 test data (including from high sensitivity and specificity rapid at-home tests with QR codes that can be uploaded), and serology information.”

Picture4

Rockerdeller Foundation’s “Getting to and Sustaining the Next Normal A Roadmap for Living with COVID

The excerpt above contains three incredibly noteworthy components: A “national program” for “immunology surveillance” using an “interoperable, electronic, national verification system.” Plans for each component are already being implemented, coincidently or not so coincidently, also under the term SHIELD. Like Shield T3, there is a little-known federal project which is also called SHIELD. For the federal data project, SHIELD is an acronym that stands for Systemic Harmonization and Interoperability of Electronic Laboratory Data. Are these two SHIELD programs related? Clearly, by subject matter, they are. And, the two SHIELD programs complement each other perfectly.

This national SHIELD program for immunology surveillance, using an interoperable, electronic, national verification system for what are apparently called “data users,” appears to be tied to every aspect of a “patient’s” life – from family to work to banking to medical care to the government. Shield T3 could very well be the data acquisition arm for the federal SHIELD surveillance and verification system.

On March 31, 2022, the Executive Director of the Health Department in Illinois’ second most populous county, Karen Ayala, testified before a committee of the U.S. House of Representatives requesting increased infrastructure funding to help overcome “data system and interoperability issues,” as she called them, to allow public health departments to know who is becoming infected and “opportunities for treatment” and “to intervene more effectively.” These and other tools requested during the hearing perfectly coincide with the suggestion outlined in the Rockefeller paper. Read Full Article >

You may also like

Leave a Comment